Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
| Market Cap | 8.24M | P/E | - | EPS this Y | - | Ern Qtrly Grth | - |
| Income | -14.68M | Forward P/E | -0.49 | EPS next Y | - | 50D Avg Chg | -8.00% |
| Sales | - | PEG | - | EPS past 5Y | - | 200D Avg Chg | -22.00% |
| Dividend | N/A | Price/Book | N/A | EPS next 5Y | - | 52W High Chg | -94.00% |
| Recommedations | - | Quick Ratio | 4.24 | Shares Outstanding | 2.05M | 52W Low Chg | 19.00% |
| Insider Own | 9.85% | ROA | -201.35% | Shares Float | 1.29M | Beta | -0.18 |
| Inst Own | 10.33% | ROE | - | Shares Shorted/Prior | 50.93K/31.54K | Price | 1.04 |
| Gross Margin | - | Profit Margin | - | Avg. Volume | 75,441 | Target Price | 8.00 |
| Oper. Margin | - | Earnings Date | Mar 17 | Volume | 52,859 | Change | 0.97% |
About Avenue Therapeutics, Inc.
Avenue Therapeutics, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of therapies for the treatment of neurologic diseases. Its product candidates include AJ201, which is in a Phase 1b/2a clinical trial for the treatment of spinal and bulbar muscular atrophy; intravenous tramadol for the treatment of post-operative acute pain; and BAER-101 for the treatment of epilepsy and panic disorders. The company was incorporated in 2015 and is based in Bay Harbor Islands, Florida. Avenue Therapeutics, Inc. is a subsidiary of Fortress Biotech, Inc.
Avenue Therapeutics, Inc. News
| Insider Trades | Relationship | Date | Transactions | Cost($) | #Shares | Value($) | #Share Own | SEC Form 4 |
|---|---|---|---|---|---|---|---|---|
| ROSENWALD LINDSAY A MD | Director Director | Sep 08 | Buy | 0.72 | 348,675 | 251,046 | 354,318 | 09/12/23 |
| Fortress Biotech, Inc. | 10% Owner 10% Owner | Sep 08 | Buy | 0.72 | 418,410 | 301,255 | 1,032,390 | 09/12/23 |
| InvaGen Pharmaceuticals, Inc. | 10% Owner 10% Owner | Oct 11 | Sell | 7.714 | 388,888 | 2,999,882 | 10/13/22 |